Ultragenyx Pharmaceutical
RARE
#4442
Rank
โ‚น214.84 B
Marketcap
โ‚น2,227
Share price
-0.44%
Change (1 day)
-42.15%
Change (1 year)

Market capitalization of Ultragenyx Pharmaceutical (RARE)

Market cap: โ‚น214.84 Billion

As of February 2026 Ultragenyx Pharmaceutical has a market cap of โ‚น214.84 Billion. This makes Ultragenyx Pharmaceutical the world's 4442th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Ultragenyx Pharmaceutical from 2014 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚น214.84 B-27.44%
2025โ‚น296.11 B-13.91%
2024โ‚น343.96 B5.22%
2023โ‚น326.89 B21.63%
2022โ‚น268.77 B-37%
2021โ‚น426.62 B-36.3%
2020โ‚น669.75 B280.2%
2019โ‚น176.15 B13.92%
2018โ‚น154.62 B22.6%
2017โ‚น126.12 B-35.4%
2016โ‚น195.22 B-32.65%
2015โ‚น289.86 B226.38%
2014โ‚น88.81 B

End of Day market cap according to different sources

On Feb 4th, 2026 the market cap of Ultragenyx Pharmaceutical was reported to be:

โ‚น214.84 Billion
by Nasdaq info icon info icon
โ‚น214.84 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Lexicon Pharmaceuticals
LXRX
โ‚น47.86 B-77.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
โ‚น73.74 B-65.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
โ‚น403.76 B 87.93%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚น998.42 B 364.71%๐Ÿ‡บ๐Ÿ‡ธ USA